
    
      The study was terminated on May 12, 2011 due to poor enrollment prospects and the study's
      similarity to another ongoing trial with ReFacto AF.

      The termination of this study has no impact on subject safety or well being. The decision to
      terminate the trial was not based on any safety concerns.
    
  